A technical view on transporters the drug pharmacokinetics dictators

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  2019-05-31

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of drug transporters and heat shock proteins during ethanol exposure to human neural precursor cells and its lineages.

  2018cited by this paper
• Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug

  2018cited by this paper
• Small Molecule PET Tracers for Transporter Imaging.

  2017cited by this paper
• Structure and allosteric inhibition of excitatory amino acid transporter 1

  2017cited by this paper
• The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives

  2016cited by this paper
• Structure-Based Identification of Inhibitors for the SLC13 Family of Na(+)/Dicarboxylate Cotransporters.

  2015cited by this paper
• Blood-brain barrier in health and disease.

  2015cited by this paper
• Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats

  2013cited by this paper
• The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

  2009cited by this paper
• Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

  2006cited by this paper
• Digoxin pharmacokinetics and MDR1 genetic polymorphisms

  2003cited by this paper
• Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series).

  2003cited by this paper
• Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats.

  2001cited by this paper
• Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations.

  1999cited by this paper
• Prescribability and switchability of highly variable drugs and drug products.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells

  1998cited by this paper
• Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption.

  1996cited by this paper
• Reduced ampicillin bioavailability following oral coadministration with chloroquine.

  1985cited by this paper
• Quantitative structure-pharmacokinetic relationships and drug design.

  1981cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Optimizing Transdermal Patch Design: A Quality by Design Approach for Dysmenorrhea Relief.

  2024cites this paper
• ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs

  2023cites this paper
• The Factorial Design of Experiments to Check Multiple Factors at Once with a Special Focus on Past Efforts in The Optimization of Gastro Retentive Microcapsules

  2022cites this paper
• Past Decade Work Done on Cubosomes and its Factorial Design: A Fast Track Information for Researchers

  2021cites this paper